SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

SELLAS Life Sciences Group, Inc. SLS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

SELLAS Life Sciences Group, Inc. (SLS) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ANVS, ARAV, AXSM, CGTX, DAWN, EFTR 等.

SLS 的市值为 $699.39M, 而同行平均市值为 $1.32B.

同行与相似公司 — SLS

Annovis Bio, Inc.

$1.76 +2.03% $34.63M

$0.04 -13.39% $2.95M

Axsome Therapeutics, Inc.

$184.18 +0.07% $9.42B

Cognition Therapeutics, Inc.

$1.09 +11.75% $80.2M

Day One Biopharmaceuticals, Inc.

$21.47 +0.05% $2.22B

eFFECTOR Therapeutics, Inc.

$0.00 0.00% $941.00

Elevation Oncology, Inc.

$0.37 -2.12% $21.63M

Enveric Biosciences, Inc.

$2.03 +4.10% $1.21M

$7.56 +3.99% $38.59M

EyePoint Pharmaceuticals, Inc.

$14.63 +2.02% $1.22B

Immix Biopharma, Inc.

$10.04 +1.93% $531.76M

Kodiak Sciences Inc.

$41.98 -6.86% $2.22B

其他人也在看

Axsome Therapeutics, Inc.

Kodiak Sciences Inc.

Day One Biopharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

Immix Biopharma, Inc.

Zura Bio Limited

Protalix BioTherapeutics, Inc.

Cassava Sciences, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言